Market Opened: Dec 7, 2023, 12:21 PM ET Volume $22,744 End Date Jul 1, 2024 Market Opened Dec 7, 2023, 12:21 PM ET Resolver 0x6A9D22261
Research from a 2023 article found significant mitochondrial structural and functional abnormalities in the muscle cells of long COVID patients, including: Disrupted cristae (mitochondrial) architecture Impaired electron transport chain function Reduced ATP production capacity These findings mirror what we see in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a condition that shares significant overlap with long COVID and is now thought to involve similar mitochondrial pathology
Symptoms often include: Constant fatigue, even with rest Brain fog and difficulty concentrating Sluggish metabolism and slow recovery after workouts Frequent illness or weakened immunity Early signs of aging like poor skin quality and low energy Instead of masking these issues, our therapies address them at the source, restoring balance and vitality from within
Ideal PCT Stack While SERMs like Clomid or Nolvadex manage hormone recovery, BPC-157 addresses the physical damage of training and steroid usesomething most PCT protocols overlook